CVS Health Corp. (CVS)

CVS Health beat expectations on both the top and bottom line in the second fiscal quarter of 2026, with results reported on Aug. 5, as revenue rose 7% to about $106.1 billion and adjusted EPS of $2.58 topped the $1.87 estimate by about 38%. Pharmacy remained the largest business, generating about $60.8 billion and growing 10%, while the broader Health Services operation also expanded to about $51.8 billion, up 12%, helping offset a more modest 4% increase in Health Care Benefits to about $37.5 billion. Gross profit reached about $15.8 billion and operating income came in at roughly $4.7 billion, with gross margin near 15% and operating margin about 4%. Net income increased 193% to $3.0 billion from $1.02 billion a year ago, and adjusted EPS was up from $1.81. Operating cash flow was about $10.6 billion, and the company paid $1.73 billion in dividends. For the next period, consensus calls for EPS of $1.72 on revenue of $103.47 billion.